Unknown

Dataset Information

0

Serum proteomic profiling in patients with drug-induced liver injury.


ABSTRACT: BACKGROUND:Idiosyncratic drug-induced liver injury (DILI) is a complex disorder that is difficult to predict, diagnose and treat. AIM:To describe the global serum proteome of patients with DILI and controls. METHODS:A label-free, mass spectrometry-based quantitative proteomic approach was used to explore protein expression in serum samples from 74 DILI patients (collected within 14 days of DILI onset) and 40 controls. A longitudinal analysis was conducted in a subset of 21 DILI patients with available 6-month follow-up serum samples. RESULTS:Comparison of DILI patients based on pattern, severity and causality assessment of liver injury revealed many differentially expressed priority 1 proteins among groups. Expression of fumarylacetoacetase was correlated with alanine aminotransferase (ALT; r = 0.237; P = 0.047), aspartate aminotransferase (AST; r = 0.389; P = 0.001) and alkaline phosphatase (r = -0.240; P = 0.043), and this was the only protein with significant differential expression when comparing patients with hepatocellular vs. cholestatic or mixed injury. In the longitudinal analysis, expression of 53 priority 1 proteins changed significantly from onset of DILI to 6-month follow-up, and nearly all proteins returned to expression levels comparable to control subjects. Ninety-two serum priority 1 proteins with significant differential expression were identified when comparing the DILI and control groups. Pattern analysis revealed proteins that are components of inflammation, immune system activation and several hepatotoxicity-specific pathways. Apolipoprotein E expression had the greatest power to differentiate DILI patients from controls (89% correct classification; AUROC = 0.97). CONCLUSION:This proteomic analysis identified differentially expressed proteins that are components of pathways previously implicated in the pathogenesis of idiosyncratic drug-induced liver injury.

SUBMITTER: Bell LN 

PROVIDER: S-EPMC3654532 | biostudies-literature | 2012 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications

Serum proteomic profiling in patients with drug-induced liver injury.

Bell L N LN   Vuppalanchi R R   Watkins P B PB   Bonkovsky H L HL   Serrano J J   Fontana R J RJ   Wang M M   Rochon J J   Chalasani N N  

Alimentary pharmacology & therapeutics 20120301 5


<h4>Background</h4>Idiosyncratic drug-induced liver injury (DILI) is a complex disorder that is difficult to predict, diagnose and treat.<h4>Aim</h4>To describe the global serum proteome of patients with DILI and controls.<h4>Methods</h4>A label-free, mass spectrometry-based quantitative proteomic approach was used to explore protein expression in serum samples from 74 DILI patients (collected within 14 days of DILI onset) and 40 controls. A longitudinal analysis was conducted in a subset of 21  ...[more]

Similar Datasets

2017-06-09 | GSE90028 | GEO
2014-01-22 | E-GEOD-54257 | biostudies-arrayexpress
| S-EPMC8088642 | biostudies-literature
| S-EPMC9163384 | biostudies-literature
2013-08-16 | E-GEOD-49631 | biostudies-arrayexpress
| S-EPMC7569965 | biostudies-literature
2014-01-22 | GSE54257 | GEO
| S-EPMC8039323 | biostudies-literature
| S-EPMC5747433 | biostudies-literature
| S-EPMC3681898 | biostudies-literature